Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients

about

Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients

Item

http://www.wikidata.org/entity/Q58712311

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Comparison of the effects of p ...... rapy in breast cancer patients

@en

Comparison of the effects of p ...... rapy in breast cancer patients

@nl

type

Item

label

Comparison of the effects of p ...... rapy in breast cancer patients

@en

Comparison of the effects of p ...... rapy in breast cancer patients

@nl

prefLabel

Comparison of the effects of p ...... rapy in breast cancer patients

@en

Comparison of the effects of p ...... rapy in breast cancer patients

@nl

P1476

Comparison of the effects of p ...... rapy in breast cancer patients

@en

P2093

Farzaneh Ashrafi

http://www.w3.org/2001/XMLSchema#string

Mehrzad Salmasi

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation.

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy.

Epidemiology and trends in breast cancer mortality in iran.

Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hell

Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.

Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/JRMS.JRMS_463_17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30181755

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

6116661

http://www.w3.org/2001/XMLSchema#string